Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$191,674,786
+$131,062,751 QoQ
Shares Held
1,438,352
+164.2% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#9
of 301 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$213,855,648
CallShares
1,604,800
PutValue
$159,991,956
PutShares
1,200,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,839,618 across 436 Biotechnology names. ABVX ranks #10 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in ABVX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,855,648 | 1,604,800 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $191,674,786 | 1,438,352 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $159,991,956 | 1,200,600 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $52,156,340 | 468,400 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $36,333,505 | 326,300 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $60,612,035 | 544,338 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $43,059,201 | 319,300 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $76,024,100 | 563,747 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $27,038,427 | 200,500 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $57,883,546 | 681,785 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $840,510 | 9,900 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $339,600 | 4,000 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $9,579,765 | 1,252,257 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,586,624 | 1,373,860 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,263,548 | 855,676 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,373,261 | 466,429 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,011,926 | 454,760 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,886,592 | 551,510 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,841,676 | 732,867 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||